1. Home
  2. PKOH vs SLDB Comparison

PKOH vs SLDB Comparison

Compare PKOH & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park-Ohio Holdings Corp.

PKOH

Park-Ohio Holdings Corp.

N/A

Current Price

$44.85

Market Cap

661.6M

Sector

Industrials

ML Signal

N/A

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

N/A

Current Price

$6.90

Market Cap

623.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PKOH
SLDB
Founded
1907
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
661.6M
623.0M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
PKOH
SLDB
Price
$44.85
$6.90
Analyst Decision
Strong Buy
Analyst Count
0
15
Target Price
★ $59.00
$18.71
AVG Volume (30 Days)
72.8K
★ 1.3M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
★ 1.07%
N/A
EPS Growth
N/A
★ 34.97
EPS
★ 2.39
N/A
Revenue
★ $1,599,100,000.00
$8,094,000.00
Revenue This Year
$7.26
N/A
Revenue Next Year
$3.99
N/A
P/E Ratio
$19.48
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$18.69
$4.16
52 Week High
$53.30
$11.45

Technical Indicators

Market Signals
Indicator
PKOH
SLDB
Relative Strength Index (RSI) 48.42 52.16
Support Level $43.76 $6.76
Resistance Level $48.74 $7.42
Average True Range (ATR) 2.89 0.51
MACD 0.32 0.17
Stochastic Oscillator 53.64 54.78

Price Performance

Historical Comparison
PKOH
SLDB

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a diversified international company offering its clients supply chain management outsourcing services, capital equipment used on their production lines, and manufactured components used to assemble their products. The company operates through three reportable segments: Supply Technologies, Assembly Components, and Engineered Products. Maximum revenue is generated from the Supply Technologies segment, which is mainly engaged in sourcing, planning, and procurement of several production components, including fasteners, pins, nuts, bolts, valves, hoses, wire harnesses, clamps and fittings, etc. Geographically, the company generates maximum revenue from its business in the United States, followed by Europe, Asia, Mexico, Canada, and other regions.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: